Cargando…
BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
BACKGROUND: Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity, mostly due to suicide rates and the presence o...
Autores principales: | Fonseca, Francina, Mestre-Pinto, Joan Ignasi, Rodríguez-Minguela, Rocío, Papaseit, Esther, Pérez-Mañá, Clara, Langohr, Klaus, Barbuti, Margherita, Farré, Magí, Torrens, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964529/ https://www.ncbi.nlm.nih.gov/pubmed/35370811 http://dx.doi.org/10.3389/fpsyt.2022.836771 |
Ejemplares similares
-
The Tryptophan System in Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2020) -
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2019) -
Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018) -
A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I(1)-Imidazoline Receptor)
por: Keller, Benjamin, et al.
Publicado: (2017) -
Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)